menu
    • menu

    Company profile for Aravax

    NEW Drugs in Dev: 2
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience. Following successful Phase 1 trials, Aravax's lead product PVX108 has received FD...
    Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience. Following successful Phase 1 trials, Aravax's lead product PVX108 has received FDA clearance to commence Phase 2 clinical trials in the United States. PVX108 is being developed to become the first safe and convenient treatment for peanut allergy.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AravaxAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 9, 31 Queen St, Melbourne, Victoria, 3000
    Telephone
    Telephone
    +61 (0)3 9657 0700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.aravax.com.au/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aravax/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aravax Adds Hellmann and Oxtoby to Its Board
    Aravax Adds Hellmann and Oxtoby to Its Board

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3269827/0/en/Aravax-Strengthens-Board-with-Appointments-of-Carsten-Hellmann-and-Andrew-Oxtoby.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    Aravax Appoints Louise as Chief Regulatory & Quality Officer
    Aravax Appoints Louise as Chief Regulatory & Quality Officer

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091587/0/en/Aravax-Appoints-Louise-Peacock-as-Chief-Regulatory-and-Quality-Officer-as-it-Prepares-for-Phase-3-Development.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Aravax Expands Globally, Names Aled As Chief Business Officer
    Aravax Expands Globally, Names Aled As Chief Business Officer

    21 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/21/3012369/0/en/Aravax-Continues-International-Expansion-with-Appointment-of-Aled-Williams-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    21 Jan 2025
    Share Share
    Aravax Establishes Development Base at Oxford Science Park
    Aravax Establishes Development Base at Oxford Science Park

    14 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/14/2980872/0/en/Aravax-Establishes-Pharmaceutical-Development-base-on-the-Oxford-Science-Park-with-a-Focus-on-Developing-Manufacturing-Capabilities-in-the-UK.html

    GLOBENEWSWIRE
    14 Nov 2024
    Share Share
    Aravax Completes Recruitment for Ph 2 Study of PVX108 Immunotherapy
    Aravax Completes Recruitment for Ph 2 Study of PVX108 Immunotherapy

    28 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/28/2969817/0/en/Aravax-Completes-Recruitment-into-Phase-2-Study-of-PVX108-a-novel-immunotherapy-for-the-Treatment-of-Peanut-Allergy.html

    GLOBENEWSWIRE
    28 Oct 2024
    Share Share
    Aravax appoints Dr Brett Haumann to Board of Directors
    Aravax appoints Dr Brett Haumann to Board of Directors

    11 May 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/20270/aravax-appoints-dr-brett-haumann-to-board-of-directors.html

    BIOSPECTRUMASIA
    11 May 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search